Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.72 |
| ▸ | LMNA | P02545 | 3/20 | 0.72 |
| ▸ | XDH | P47989 | 2/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.72 |
| ▸ | GFER | P55789 | 1/20 | 0.72 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.72 |
| ▸ | RELA | Q04206 | 1/20 | 0.72 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.72 |
| ▸ | CA1 | P00915 | 4/20 | 0.61 |
| ▸ | CA2 | P00918 | 4/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.61 |
| ▸ | CA7 | P43166 | 3/20 | 0.61 |
| ▸ | CA9 | Q16790 | 3/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.61 |
| ▸ | CNR2 | P34972 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1134668 | 0.88 | TPMT (0.73) | KDM4ELMNAXDHTDP1POLB | |
| SCHEMBL27898473 | 0.88 | LMNA (0.62) | KDM4ELMNAXDHTDP1POLB | |
| SCHEMBL1056601 | 0.86 | LMNA (0.66) | KDM4ELMNAXDHTDP1POLB | |
| Gallic Acid Methyl Ester SCHEMBL39513 | 0.84 | KDM4E (1.00) | KDM4ELMNAXDHTDP1POLB | |
| SCHEMBL16503507 | 0.83 | KDM4E (0.67) | KDM4ELMNAXDHTDP1POLB | |
| SCHEMBL8357710 | 0.82 | CA12 (0.61) | KDM4ELMNAXDHTDP1POLB | |
| Gallic Acid Methyl Ester SCHEMBL21611341 | 0.82 | KDM4E (0.95) | KDM4ELMNAXDHTDP1POLB | |
| Gallic Acid Methyl Ester SCHEMBL21543905 | 0.82 | KDM4E (0.95) | KDM4ELMNAXDHTDP1POLB | |
| SCHEMBL1919075 | 0.82 | KDM4E (0.72) | KDM4ELMNAXDHTDP1POLB | |
| Gallic Acid Methyl Ester SCHEMBL28556619 | 0.82 | KDM4E (0.95) | KDM4ELMNAXDHTDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130310332-A1 | MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF | UNIVERSITY OF RHODE ISLAND (US) | 2013-11-21 | — | — | US | claimed |
| WO-2012055010-A1 | MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF | FÉDÉRATION DES PRODUCTEURS ACÉRICOLES DU QUÉBEC (CA) | 2012-05-03 | — | — | WO | claimed |
| EP-0239423-A2 | Positive type radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1987-09-30 | — | — | EP | claimed |
| US-20250223462-A1 | ELECTRONIC COMPONENT | NIHON PARKERIZING CO., LTD. (JP) | 2025-07-10 | — | — | US | disclosed |
| CN-119013434-A | Electronic component | 日本帕卡濑精株式会社 | 2024-11-22 | — | — | CN | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| WO-2023235464-A1 | NOVEL EQUILIBRATIVE NUCLEOSIDE TRANSPORTER INHIBITORS AND METHODS OF MAKING AND USING SAME | DUKE UNIVERSITY (US) | 2023-12-07 | — | — | WO | disclosed |
| WO-2023195439-A1 | ELECTRONIC COMPONENT | 日本パーカライジング株式会社 | 2023-10-12 | — | — | WO | disclosed |
| US-11339179-B2 | Preparation for natural product trabectedin | CE PHARM CO., LTD. (CN) | 2022-05-24 | — | — | US | disclosed |
| US-20210171883-A1 | ANTIVIRAL WIPER | FUJIFILM CORPORATION (JP) | 2021-06-10 | — | — | US | disclosed |
| US-20210163500-A1 | PREPARATION FOR NATURAL PRODUCT TRABECTEDIN | CE PHARM CO., LTD. (CN) | 2021-06-03 | — | — | US | disclosed |
| US-20030027814-A1 | Bis(5-aryl-2-pyridyl) derivatives | KOWA CO., LTD. (JP) | 2003-02-06 | — | — | US | disclosed |
| US-5635329-A | QUINONEDIAZIDE, SOLVENT AND SPECIFIC ALKALI-SOLUBLE NOVOLAK RESINS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-06-03 | — | — | US | disclosed |
| EP-0239423-B1 | Positive type radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO LTD (JP) | 1996-03-20 | — | — | EP | disclosed |
| US-5447825-A | Photoresists, patterns on semiconductors, phenolic resin, quinonediazide | MITSUBISHI CHEMICAL CORPORATION (JP) | 1995-09-05 | — | — | US | disclosed |
| EP-0660186-A1 | Photosensitive resin composition and method for forming a pattern using the composition | Mitsubishi Chemical Corporation (JP) | 1995-06-28 | — | — | EP | disclosed |
| US-5372909-A | High resolution level, large exposure margin; photoresists | MITSUBISHI KASEI CORPORATION (JP) | 1994-12-13 | — | — | US | disclosed |
| US-5019479-A | Photoresists for integrated circuits | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-05-28 | — | — | US | disclosed |
| EP-0239423-A2 | Positive type radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1987-09-30 | — | — | EP | disclosed |
| US-4009208-A | N,N'-HEPTAMETHYLENEBIS(4-METHOXYBENZAMIDE) | STERLING DRUG INC. (US) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163500-A1 | PREPARATION FOR NATURAL PRODUCT TRABECTEDIN | TH, TYR, FLT4 | KDM4E 791/4885LMNA 3249/4885XDH 956/4885 |
| US-20210171883-A1 | ANTIVIRAL WIPER | CGAS, PRKX, PDE4C | KDM4E 523/4885LMNA 1615/4885XDH 169/4885 |
| US-20030027814-A1 | Bis(5-aryl-2-pyridyl) derivatives | AHR, PAH, H1-0 | KDM4E 1363/4885LMNA 1526/4885XDH 51/4885 |
| US-11339179-B2 | Preparation for natural product trabectedin | TH, TYR, FLT4 | KDM4E 791/4885LMNA 3249/4885XDH 956/4885 |
| US-20130310332-A1 | MAPLE TREE-DERIVED PRODUCTS AND USES THEREOF | FASN, NNT, MAPK7 | KDM4E 4065/4885LMNA 623/4885XDH 2582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.